Equities Analysts Issue Forecasts for Trillium Therapeutics Inc’s Q3 2018 Earnings (TRIL)

Trillium Therapeutics Inc (NASDAQ:TRIL) (TSE:TR) – Equities research analysts at Leerink Swann upped their Q3 2018 earnings per share (EPS) estimates for shares of Trillium Therapeutics in a report released on Wednesday, November 14th. Leerink Swann analyst J. Chang now expects that the biotechnology company will post earnings of ($0.69) per share for the quarter, up from their prior forecast of ($0.78). Leerink Swann also issued estimates for Trillium Therapeutics’ Q4 2018 earnings at ($0.78) EPS, FY2018 earnings at ($2.42) EPS and FY2019 earnings at ($1.34) EPS.

Scientific Games Corp (SGMS) Plunges 6.34% on November 16

Scientific Games Corp (SGMS) had a rough trading day for Friday November 16 as shares tumbled 6.34%, or a loss of $-1.265 per share, to close at $18.70. After opening the day at $19.00, shares of Scientific Games Corp traded as high as $19.25 and as low as $17.91. Volume was 3.12 million shares over 19,397 trades, against an average daily volume of n/a shares and a total float of 91.71 million.

error: Content is protected !!